🇺🇸 FDA
Patent

US 8304433

Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound

granted A61KA61K31/4465A61P

Quick answer

US patent 8304433 (Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound) held by Theravance, Inc. expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4465, A61P, A61P11/06, A61P13/00